GOUT RELIEF 3310-S- medicago sativa whole chicory root capsule

Gout Relief 3310-S by

Drug Labeling and Warnings

Gout Relief 3310-S by is a Homeopathic medication manufactured, distributed, or labeled by Bispit Canada Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

MEDICAGO SATIVA WHOLE 20.00%
CHICORY ROOT 23.00%
GLUCOSAMINE HYDROCHLORIDE 10.00%
BUCKWHEAT 7.00%
TEA LEAF 5.00%
MORUS ALBA LEAF 13.00%
LICORICE 0.20%
FU LING 2.00%
COIX LACRYMA-JOBI SEED 8.00%

INACTIVE INGREDIENT

This product has a significanteffect on gout, crystal deposits,and hyperuricemia;
elt has an auxiliary effectof mitigating kidney stonesand bladder stones

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children

DOSAGE & ADMINISTRATION

The product has great somatosensation after taking it atleast 21 days in the earty stage;3. Elevated uric acid or gout recurrence and site changes arenoral in the earty stage of taking this product;

INDICATIONS & USAGE

Dissolved CrystallizationKidney StoneGallstone< Urinary Calculus

OTHER SAFETY INFORMATION

Do not use if seal is broken.

Do not eat freshness packet enclosed.

Keep out of direct sunlight, high temperature, and humidity.

Store in a cool, dry place.

WARNINGS

For your health, please read the followingcarefully
1. The use of three vials can effectivety dissolve crystallization (ittakes time to dissolve crystallization);2. The product has great somatosensation after taking it atleast 21 days in the early stage;3. Elevated uric acid or gout recurrence and site changes arenormal in the early stage of taking this product;4. Try not to drink alcohol or drink less 15 days before takingthis product;
5. This product certainly has significant effect on gout,crystallization and hyperuricemia;

PURPOSE

This product has a significanteffect on gout, crystal deposits,and hyperuricemia; elt has an auxiliary effectof mitigating kidney stonesand bladder stones

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

GOUT RELIEF 3310-S 
medicago sativa whole chicory root capsule

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 85631-006
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
COIX LACRYMA-JOBI SEED (UNII: 4Q4V6NTZ1F) (COIX LACRYMA-JOBI SEED - UNII:4Q4V6NTZ1F)	COIX LACRYMA-JOBI SEED	104 mg  in 1.3 g
MEDICAGO SATIVA WHOLE (UNII: DJO934BRBD) (MEDICAGO SATIVA WHOLE - UNII:DJO934BRBD)	MEDICAGO SATIVA WHOLE	260 mg  in 1.3 g
BUCKWHEAT (UNII: N0Y68724R3) (BUCKWHEAT - UNII:N0Y68724R3)	BUCKWHEAT	91 mg  in 1.3 g
TEA LEAF (UNII: GH42T47V24) (TEA LEAF - UNII:GH42T47V24)	TEA LEAF	65 mg  in 1.3 g
MORUS ALBA LEAF (UNII: M8YIA49Q2P) (MORUS ALBA LEAF - UNII:M8YIA49Q2P)	MORUS ALBA LEAF	169 mg  in 1.3 g
CHICORY ROOT (UNII: 090CTY533N) (CHICORY ROOT - UNII:090CTY533N)	CHICORY ROOT	299 mg  in 1.3 g
FU LING (UNII: XH37TWY5O4) (FU LING - UNII:XH37TWY5O4)	FU LING	26 mg  in 1.3 g
GLUCOSAMINE HYDROCHLORIDE (UNII: 750W5330FY) (GLUCOSAMINE - UNII:N08U5BOQ1K)	GLUCOSAMINE HYDROCHLORIDE	130 mg  in 1.3 g
LICORICE (UNII: 61ZBX54883) (LICORICE - UNII:61ZBX54883)	LICORICE	2.6 mg  in 1.3 g

Inactive Ingredients
Ingredient Name	Strength
MALTOSYL-ISOMALTOTETRAOSE (UNII: B9HR7A9UFR)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311)

Product Characteristics
Color	white	Score	score with uneven pieces
Shape	CAPSULE	Size	20mm
Flavor		Imprint Code
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 85631-006-01	60 in 1 BOTTLE	09/01/2025
1		1.3 g in 1 CAPSULE; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved homeopathic		09/01/2025

Labeler - Bispit Canada Ltd. (243332192)

Registrant - Bispit Canada Ltd. (243332192)